1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Human Vaccine Segment by Type

2.2.1 Varicella

2.2.2 Influenza

2.2.3 Polio

2.2.4 Hepatitis A

2.2.5 Rabies

2.2.6 BCG

2.2.7 Hepatitis B

2.2.8 Pertussis, Diphtheria, Tetanus

2.2.9 Pneumococcal

2.2.10 Rota vaccine

2.3 Human Vaccine Sales by Type

2.3.1 Global Human Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Human Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Vaccine Sale Price by Type (2017-2022)

2.4 Human Vaccine Segment by Application

2.4.1 Adults

2.4.2 Children

2.5 Human Vaccine Sales by Application

2.5.1 Global Human Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Human Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Vaccine Sale Price by Application (2017-2022)

3 Global Human Vaccine by Company

3.1 Global Human Vaccine Breakdown Data by Company

3.1.1 Global Human Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Human Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Human Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Human Vaccine Revenue by Company (2020-2022)

3.2.2 Global Human Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Human Vaccine Sale Price by Company

3.4 Key Manufacturers Human Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Vaccine Product Location Distribution

3.4.2 Players Human Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Vaccine by Geographic Region

4.1 World Historic Human Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Vaccine Annual Revenue by Geographic Region

4.2 World Historic Human Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Human Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Vaccine Annual Revenue by Country/Region

4.3 Americas Human Vaccine Sales Growth

4.4 APAC Human Vaccine Sales Growth

4.5 Europe Human Vaccine Sales Growth

4.6 Middle East & Africa Human Vaccine Sales Growth

5 Americas

5.1 Americas Human Vaccine Sales by Country

5.1.1 Americas Human Vaccine Sales by Country (2017-2022)

5.1.2 Americas Human Vaccine Revenue by Country (2017-2022)

5.2 Americas Human Vaccine Sales by Type

5.3 Americas Human Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Vaccine Sales by Region

6.1.1 APAC Human Vaccine Sales by Region (2017-2022)

6.1.2 APAC Human Vaccine Revenue by Region (2017-2022)

6.2 APAC Human Vaccine Sales by Type

6.3 APAC Human Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Vaccine by Country

7.1.1 Europe Human Vaccine Sales by Country (2017-2022)

7.1.2 Europe Human Vaccine Revenue by Country (2017-2022)

7.2 Europe Human Vaccine Sales by Type

7.3 Europe Human Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Vaccine by Country

8.1.1 Middle East & Africa Human Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Vaccine Sales by Type

8.3 Middle East & Africa Human Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Vaccine

10.3 Manufacturing Process Analysis of Human Vaccine

10.4 Industry Chain Structure of Human Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Vaccine Distributors

11.3 Human Vaccine Customer

12 World Forecast Review for Human Vaccine by Geographic Region

12.1 Global Human Vaccine Market Size Forecast by Region

12.1.1 Global Human Vaccine Forecast by Region (2023-2028)

12.1.2 Global Human Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Vaccine Forecast by Type

12.7 Global Human Vaccine Forecast by Application

13 Key Players Analysis

13.1 CNBG

13.1.1 CNBG Company Information

13.1.2 CNBG Human Vaccine Product Offered

13.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CNBG Main Business Overview

13.1.5 CNBG Latest Developments

13.2 Changsheng Life

13.2.1 Changsheng Life Company Information

13.2.2 Changsheng Life Human Vaccine Product Offered

13.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Changsheng Life Main Business Overview

13.2.5 Changsheng Life Latest Developments

13.3 Zhifei

13.3.1 Zhifei Company Information

13.3.2 Zhifei Human Vaccine Product Offered

13.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zhifei Main Business Overview

13.3.5 Zhifei Latest Developments

13.4 ChengDa Bio

13.4.1 ChengDa Bio Company Information

13.4.2 ChengDa Bio Human Vaccine Product Offered

13.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 ChengDa Bio Main Business Overview

13.4.5 ChengDa Bio Latest Developments

13.5 Kangtai

13.5.1 Kangtai Company Information

13.5.2 Kangtai Human Vaccine Product Offered

13.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Kangtai Main Business Overview

13.5.5 Kangtai Latest Developments

13.6 SINOVAC BIOTECH

13.6.1 SINOVAC BIOTECH Company Information

13.6.2 SINOVAC BIOTECH Human Vaccine Product Offered

13.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 SINOVAC BIOTECH Main Business Overview

13.6.5 SINOVAC BIOTECH Latest Developments

13.7 Hissen

13.7.1 Hissen Company Information

13.7.2 Hissen Human Vaccine Product Offered

13.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hissen Main Business Overview

13.7.5 Hissen Latest Developments

13.8 Walvax Biotechnology

13.8.1 Walvax Biotechnology Company Information

13.8.2 Walvax Biotechnology Human Vaccine Product Offered

13.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Walvax Biotechnology Main Business Overview

13.8.5 Walvax Biotechnology Latest Developments

13.9 GSK

13.9.1 GSK Company Information

13.9.2 GSK Human Vaccine Product Offered

13.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GSK Main Business Overview

13.9.5 GSK Latest Developments

13.10 SANOFI

13.10.1 SANOFI Company Information

13.10.2 SANOFI Human Vaccine Product Offered

13.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 SANOFI Main Business Overview

13.10.5 SANOFI Latest Developments

13.11 Rong An

13.11.1 Rong An Company Information

13.11.2 Rong An Human Vaccine Product Offered

13.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Rong An Main Business Overview

13.11.5 Rong An Latest Developments

13.12 NuoCheng Bio

13.12.1 NuoCheng Bio Company Information

13.12.2 NuoCheng Bio Human Vaccine Product Offered

13.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 NuoCheng Bio Main Business Overview

13.12.5 NuoCheng Bio Latest Developments

13.13 Hualan Bio

13.13.1 Hualan Bio Company Information

13.13.2 Hualan Bio Human Vaccine Product Offered

13.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hualan Bio Main Business Overview

13.13.5 Hualan Bio Latest Developments

13.14 Tiantan biological

13.14.1 Tiantan biological Company Information

13.14.2 Tiantan biological Human Vaccine Product Offered

13.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Tiantan biological Main Business Overview

13.14.5 Tiantan biological Latest Developments

13.15 Changchun Baike

13.15.1 Changchun Baike Company Information

13.15.2 Changchun Baike Human Vaccine Product Offered

13.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Changchun Baike Main Business Overview

13.15.5 Changchun Baike Latest Developments

13.16 Adimmune

13.16.1 Adimmune Company Information

13.16.2 Adimmune Human Vaccine Product Offered

13.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Adimmune Main Business Overview

13.16.5 Adimmune Latest Developments

13.17 Zhongyianke Biotech

13.17.1 Zhongyianke Biotech Company Information

13.17.2 Zhongyianke Biotech Human Vaccine Product Offered

13.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Zhongyianke Biotech Main Business Overview

13.17.5 Zhongyianke Biotech Latest Developments

13.18 Bharat Biotech

13.18.1 Bharat Biotech Company Information

13.18.2 Bharat Biotech Human Vaccine Product Offered

13.18.3 Bharat Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Bharat Biotech Main Business Overview

13.18.5 Bharat Biotech Latest Developments

13.19 Bavarian Nordic

13.19.1 Bavarian Nordic Company Information

13.19.2 Bavarian Nordic Human Vaccine Product Offered

13.19.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Bavarian Nordic Main Business Overview

13.19.5 Bavarian Nordic Latest Developments

13.20 Sanofi-Pasteur

13.20.1 Sanofi-Pasteur Company Information

13.20.2 Sanofi-Pasteur Human Vaccine Product Offered

13.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Sanofi-Pasteur Main Business Overview

13.20.5 Sanofi-Pasteur Latest Developments

13.21 Indian Immunologicals

13.21.1 Indian Immunologicals Company Information

13.21.2 Indian Immunologicals Human Vaccine Product Offered

13.21.3 Indian Immunologicals Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Indian Immunologicals Main Business Overview

13.21.5 Indian Immunologicals Latest Developments

13.22 KANGH

13.22.1 KANGH Company Information

13.22.2 KANGH Human Vaccine Product Offered

13.22.3 KANGH Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 KANGH Main Business Overview

13.22.5 KANGH Latest Developments

13.23 Henan Grand Biopharma

13.23.1 Henan Grand Biopharma Company Information

13.23.2 Henan Grand Biopharma Human Vaccine Product Offered

13.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Henan Grand Biopharma Main Business Overview

13.23.5 Henan Grand Biopharma Latest Developments

13.24 ZhongKe Biopharm

13.24.1 ZhongKe Biopharm Company Information

13.24.2 ZhongKe Biopharm Human Vaccine Product Offered

13.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 ZhongKe Biopharm Main Business Overview

13.24.5 ZhongKe Biopharm Latest Developments

13.25 Zhuoyi Biological

13.25.1 Zhuoyi Biological Company Information

13.25.2 Zhuoyi Biological Human Vaccine Product Offered

13.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Zhuoyi Biological Main Business Overview

13.25.5 Zhuoyi Biological Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Varicella

Table 4. Major Players of Influenza

Table 5. Major Players of Polio

Table 6. Major Players of Hepatitis A

Table 7. Major Players of Rabies

Table 8. Major Players of BCG

Table 9. Major Players of Hepatitis B

Table 10. Major Players of Pertussis, Diphtheria, Tetanus

Table 11. Major Players of Pneumococcal

Table 12. Major Players of Rota vaccine

Table 13. Global Human Vaccine Sales by Type (2017-2022) & (M Doses)

Table 14. Global Human Vaccine Sales Market Share by Type (2017-2022)

Table 15. Global Human Vaccine Revenue by Type (2017-2022) & ($ million)

Table 16. Global Human Vaccine Revenue Market Share by Type (2017-2022)

Table 17. Global Human Vaccine Sale Price by Type (2017-2022) & (USD/Dose)

Table 18. Global Human Vaccine Sales by Application (2017-2022) & (M Doses)

Table 19. Global Human Vaccine Sales Market Share by Application (2017-2022)

Table 20. Global Human Vaccine Revenue by Application (2017-2022)

Table 21. Global Human Vaccine Revenue Market Share by Application (2017-2022)

Table 22. Global Human Vaccine Sale Price by Application (2017-2022) & (USD/Dose)

Table 23. Global Human Vaccine Sales by Company (2020-2022) & (M Doses)

Table 24. Global Human Vaccine Sales Market Share by Company (2020-2022)

Table 25. Global Human Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 26. Global Human Vaccine Revenue Market Share by Company (2020-2022)

Table 27. Global Human Vaccine Sale Price by Company (2020-2022) & (USD/Dose)

Table 28. Key Manufacturers Human Vaccine Producing Area Distribution and Sales Area

Table 29. Players Human Vaccine Products Offered

Table 30. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 31. New Products and Potential Entrants

Table 32. Mergers & Acquisitions, Expansion

Table 33. Global Human Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 34. Global Human Vaccine Sales Market Share Geographic Region (2017-2022)

Table 35. Global Human Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 36. Global Human Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 37. Global Human Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 38. Global Human Vaccine Sales Market Share by Country/Region (2017-2022)

Table 39. Global Human Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 40. Global Human Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 41. Americas Human Vaccine Sales by Country (2017-2022) & (M Doses)

Table 42. Americas Human Vaccine Sales Market Share by Country (2017-2022)

Table 43. Americas Human Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 44. Americas Human Vaccine Revenue Market Share by Country (2017-2022)

Table 45. Americas Human Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. Americas Human Vaccine Sales Market Share by Type (2017-2022)

Table 47. Americas Human Vaccine Sales by Application (2017-2022) & (M Doses)

Table 48. Americas Human Vaccine Sales Market Share by Application (2017-2022)

Table 49. APAC Human Vaccine Sales by Region (2017-2022) & (M Doses)

Table 50. APAC Human Vaccine Sales Market Share by Region (2017-2022)

Table 51. APAC Human Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 52. APAC Human Vaccine Revenue Market Share by Region (2017-2022)

Table 53. APAC Human Vaccine Sales by Type (2017-2022) & (M Doses)

Table 54. APAC Human Vaccine Sales Market Share by Type (2017-2022)

Table 55. APAC Human Vaccine Sales by Application (2017-2022) & (M Doses)

Table 56. APAC Human Vaccine Sales Market Share by Application (2017-2022)

Table 57. Europe Human Vaccine Sales by Country (2017-2022) & (M Doses)

Table 58. Europe Human Vaccine Sales Market Share by Country (2017-2022)

Table 59. Europe Human Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Europe Human Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Europe Human Vaccine Sales by Type (2017-2022) & (M Doses)

Table 62. Europe Human Vaccine Sales Market Share by Type (2017-2022)

Table 63. Europe Human Vaccine Sales by Application (2017-2022) & (M Doses)

Table 64. Europe Human Vaccine Sales Market Share by Application (2017-2022)

Table 65. Middle East & Africa Human Vaccine Sales by Country (2017-2022) & (M Doses)

Table 66. Middle East & Africa Human Vaccine Sales Market Share by Country (2017-2022)

Table 67. Middle East & Africa Human Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 68. Middle East & Africa Human Vaccine Revenue Market Share by Country (2017-2022)

Table 69. Middle East & Africa Human Vaccine Sales by Type (2017-2022) & (M Doses)

Table 70. Middle East & Africa Human Vaccine Sales Market Share by Type (2017-2022)

Table 71. Middle East & Africa Human Vaccine Sales by Application (2017-2022) & (M Doses)

Table 72. Middle East & Africa Human Vaccine Sales Market Share by Application (2017-2022)

Table 73. Key Market Drivers & Growth Opportunities of Human Vaccine

Table 74. Key Market Challenges & Risks of Human Vaccine

Table 75. Key Industry Trends of Human Vaccine

Table 76. Human Vaccine Raw Material

Table 77. Key Suppliers of Raw Materials

Table 78. Human Vaccine Distributors List

Table 79. Human Vaccine Customer List

Table 80. Global Human Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 81. Global Human Vaccine Sales Market Forecast by Region

Table 82. Global Human Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Global Human Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 84. Americas Human Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 85. Americas Human Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. APAC Human Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 87. APAC Human Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 88. Europe Human Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 89. Europe Human Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Middle East & Africa Human Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 91. Middle East & Africa Human Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 92. Global Human Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 93. Global Human Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 94. Global Human Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 95. Global Human Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 96. Global Human Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 97. Global Human Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 98. Global Human Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 99. Global Human Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 100. CNBG Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 101. CNBG Human Vaccine Product Offered

Table 102. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 103. CNBG Main Business

Table 104. CNBG Latest Developments

Table 105. Changsheng Life Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 106. Changsheng Life Human Vaccine Product Offered

Table 107. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 108. Changsheng Life Main Business

Table 109. Changsheng Life Latest Developments

Table 110. Zhifei Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 111. Zhifei Human Vaccine Product Offered

Table 112. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 113. Zhifei Main Business

Table 114. Zhifei Latest Developments

Table 115. ChengDa Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 116. ChengDa Bio Human Vaccine Product Offered

Table 117. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 118. ChengDa Bio Main Business

Table 119. ChengDa Bio Latest Developments

Table 120. Kangtai Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 121. Kangtai Human Vaccine Product Offered

Table 122. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 123. Kangtai Main Business

Table 124. Kangtai Latest Developments

Table 125. SINOVAC BIOTECH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 126. SINOVAC BIOTECH Human Vaccine Product Offered

Table 127. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 128. SINOVAC BIOTECH Main Business

Table 129. SINOVAC BIOTECH Latest Developments

Table 130. Hissen Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 131. Hissen Human Vaccine Product Offered

Table 132. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 133. Hissen Main Business

Table 134. Hissen Latest Developments

Table 135. Walvax Biotechnology Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 136. Walvax Biotechnology Human Vaccine Product Offered

Table 137. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 138. Walvax Biotechnology Main Business

Table 139. Walvax Biotechnology Latest Developments

Table 140. GSK Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 141. GSK Human Vaccine Product Offered

Table 142. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 143. GSK Main Business

Table 144. GSK Latest Developments

Table 145. SANOFI Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 146. SANOFI Human Vaccine Product Offered

Table 147. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 148. SANOFI Main Business

Table 149. SANOFI Latest Developments

Table 150. Rong An Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 151. Rong An Human Vaccine Product Offered

Table 152. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 153. Rong An Main Business

Table 154. Rong An Latest Developments

Table 155. NuoCheng Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 156. NuoCheng Bio Human Vaccine Product Offered

Table 157. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 158. NuoCheng Bio Main Business

Table 159. NuoCheng Bio Latest Developments

Table 160. Hualan Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 161. Hualan Bio Human Vaccine Product Offered

Table 162. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 163. Hualan Bio Main Business

Table 164. Hualan Bio Latest Developments

Table 165. Tiantan biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 166. Tiantan biological Human Vaccine Product Offered

Table 167. Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 168. Tiantan biological Main Business

Table 169. Tiantan biological Latest Developments

Table 170. Changchun Baike Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 171. Changchun Baike Human Vaccine Product Offered

Table 172. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 173. Changchun Baike Main Business

Table 174. Changchun Baike Latest Developments

Table 175. Adimmune Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 176. Adimmune Human Vaccine Product Offered

Table 177. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 178. Adimmune Main Business

Table 179. Adimmune Latest Developments

Table 180. Zhongyianke Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 181. Zhongyianke Biotech Human Vaccine Product Offered

Table 182. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 183. Zhongyianke Biotech Main Business

Table 184. Zhongyianke Biotech Latest Developments

Table 185. Bharat Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 186. Bharat Biotech Human Vaccine Product Offered

Table 187. Bharat Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 188. Bharat Biotech Main Business

Table 189. Bharat Biotech Latest Developments

Table 190. Bavarian Nordic Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 191. Bavarian Nordic Human Vaccine Product Offered

Table 192. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 193. Bavarian Nordic Main Business

Table 194. Bavarian Nordic Latest Developments

Table 195. Sanofi-Pasteur Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 196. Sanofi-Pasteur Human Vaccine Product Offered

Table 197. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 198. Sanofi-Pasteur Main Business

Table 199. Sanofi-Pasteur Latest Developments

Table 200. Indian Immunologicals Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 201. Indian Immunologicals Human Vaccine Product Offered

Table 202. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 203. Indian Immunologicals Main Business

Table 204. Indian Immunologicals Latest Developments

Table 205. KANGH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 206. KANGH Human Vaccine Product Offered

Table 207. KANGH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 208. KANGH Main Business

Table 209. KANGH Latest Developments

Table 210. Henan Grand Biopharma Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 211. Henan Grand Biopharma Human Vaccine Product Offered

Table 212. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 213. Henan Grand Biopharma Main Business

Table 214. Henan Grand Biopharma Latest Developments

Table 215. ZhongKe Biopharm Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 216. ZhongKe Biopharm Human Vaccine Product Offered

Table 217. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 218. ZhongKe Biopharm Main Business

Table 219. ZhongKe Biopharm Latest Developments

Table 220. Zhuoyi Biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 221. Zhuoyi Biological Human Vaccine Product Offered

Table 222. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 223. Zhuoyi Biological Main Business

Table 224. Zhuoyi Biological Latest Developments

List of Figures

Figure 1. Picture of Human Vaccine

Figure 2. Human Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Human Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Varicella

Figure 10. Product Picture of Influenza

Figure 11. Product Picture of Polio

Figure 12. Product Picture of Hepatitis A

Figure 13. Product Picture of Rabies

Figure 14. Product Picture of BCG

Figure 15. Product Picture of Hepatitis B

Figure 16. Product Picture of Pertussis, Diphtheria, Tetanus

Figure 17. Product Picture of Pneumococcal

Figure 18. Product Picture of Rota vaccine

Figure 19. Global Human Vaccine Sales Market Share by Type in 2021

Figure 20. Global Human Vaccine Revenue Market Share by Type (2017-2022)

Figure 21. Human Vaccine Consumed in Adults

Figure 22. Global Human Vaccine Market: Adults (2017-2022) & (M Doses)

Figure 23. Human Vaccine Consumed in Children

Figure 24. Global Human Vaccine Market: Children (2017-2022) & (M Doses)

Figure 25. Global Human Vaccine Sales Market Share by Application (2017-2022)

Figure 26. Global Human Vaccine Revenue Market Share by Application in 2021

Figure 27. Human Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Human Vaccine Revenue Market Share by Company in 2021

Figure 29. Global Human Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Human Vaccine Revenue Market Share by Geographic Region in 2021

Figure 31. Global Human Vaccine Sales Market Share by Region (2017-2022)

Figure 32. Global Human Vaccine Revenue Market Share by Country/Region in 2021

Figure 33. Americas Human Vaccine Sales 2017-2022 (M Doses)

Figure 34. Americas Human Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. APAC Human Vaccine Sales 2017-2022 (M Doses)

Figure 36. APAC Human Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Europe Human Vaccine Sales 2017-2022 (M Doses)

Figure 38. Europe Human Vaccine Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Human Vaccine Sales 2017-2022 (M Doses)

Figure 40. Middle East & Africa Human Vaccine Revenue 2017-2022 ($ Millions)

Figure 41. Americas Human Vaccine Sales Market Share by Country in 2021

Figure 42. Americas Human Vaccine Revenue Market Share by Country in 2021

Figure 43. United States Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Human Vaccine Sales Market Share by Region in 2021

Figure 48. APAC Human Vaccine Revenue Market Share by Regions in 2021

Figure 49. China Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Human Vaccine Sales Market Share by Country in 2021

Figure 56. Europe Human Vaccine Revenue Market Share by Country in 2021

Figure 57. Germany Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Human Vaccine Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Human Vaccine Revenue Market Share by Country in 2021

Figure 64. Egypt Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Human Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Human Vaccine in 2021

Figure 70. Manufacturing Process Analysis of Human Vaccine

Figure 71. Industry Chain Structure of Human Vaccine

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles